About Us

“ICTS helped us complete enrollment by cutting our time lines by more than 65% by providing services that began at project launch. Their level of commitment to our success is illustrated in every stage of development and implementation.”
Vice President of Clinical Operations, Biotechnology Firm


ICTS management is composed of several pioneers in centralized enrollment strategies. Our core team has combined experience of over 35 years providing service to more than 500 protocols in over 38 countries.

Tom Sturgis, President and CEO

Tom has spent the last fifteen years working exclusively in pharmaceutical marketing and patient recruitment in clinical trials. He has managed all operational activities including:


  • Sales & marketing
  • Program design
  • Project management
  • Proposal preparation and presentation
  • Creative & production services
  • Media planning and research
  • Call center operations
  • Contract preparation and execution
  • Financial and HR responsibilities


Tom has helped orchestrate over 150 patient recruitment programs in more than 20 therapeutic areas involving millions of potential study patients. Successful enrollment in these studies has helped shave years off development timelines for clients.

Gregg Sweet, Vice President, Strategy and Development

Gregg joined ICTS as one of its founding partners after having successfully operated his own firm since 1995, Clinical Communications Group, a patient recruitment company. He is responsible for the development of ICTS products and client strategy, working with sponsors to develop and implement integrated tactics to increase the efficiency of clinical trial investigator meetings, patient recruitment, enrollment conversion, retention and post-marketing programs.

Gregg has successfully planned and executed over 150 patient recruitment programs including international, full-scale centralized recruitment programs involving over 20,000 subjects. He works closely with sponsors to identify processes that can decrease cost and increase operational efficiency by providing a flexible, zero-base planning method focused entirely on the specific requirements of the protocol.





Council of Medical Advisors

ICTS has nurtured and developed close relationships with several highly qualified clinical professionals.  We call upon these experts for project assistance when their particular expertise can provide invaluable help to our clients.  A complete understanding of the most intricate details of the study processes and demand high quality patients to ensure high quality data is essential.  To that end we have formed a Council of Medical Advisors to enhance the quality of ICTS work and to provide our clients with access to some of the industry's top professionals in the global research community.

Each of the members of the ICTS council has vast experience in clinical research and serves to augment our services by either leading a specialized project such as a Medical Science Liaison (MSL) program, providing medical content for communication pieces or advising on clinical challenges and operations.

Darron R. Brown, MD

Darron R. Brown, MD
Professor of Medicine, Microbiology, and Immunology
Indiana University School of Medicine
Darron Brown received his M.D., Internal Medicine training, and Infectious Diseases sub-specialty training at the University of Rochester School of Medicine and Dentistry, Rochester, NY, and is Board Certified in Internal Medicine and Infectious Diseases.  He is currently Professor of Medicine, Microbiology, and Immunology at the Indiana University School of Medicine.  He is an attending physician at the Indiana University Hospital, Wishard Memorial Hospital, and the Roudebush Veterans Administration Hospital. 
Dr. Brown received the Burroughs Wellcome Fund Young Investigator Award in Virology from the Infectious Diseases Society of America in 1991, the Tony and Mary Hulman Health Achievement Award in Public Health, Indiana Public Health Foundation, 2006, and the Clinical Trial Exceptional Service Award for Development of the Quadrivalent Human Papillomavirus (HPV) vaccine (Gardasil) from the Pharmaceutical Research and Manufacturers of America in 2009.
Beginning in 1985, his laboratory has focused on the mechanisms of transmission of HPV infection, HPV-related oncogenesis, and prevention of HPV-related disease through development of vaccines.  He has performed extensive pre-clinical studies of vaccines and has conducted eleven human vaccine trials at all stages of development.  Dr. Brown has published approximately 100 research articles and book chapters on human papillomaviruses and vaccines.  He serves as a consultant to industry related to HPV and development of novel vaccines.

Eugene Selivra, MD

Eugene Selivra, MD
CEO Global Clinical Trials, LLC
CEO Global Medical Institutes, LLC
Eugene Selivra, M.D. is Chief Executive Officer of Global Clinical Trials, LLC a premium Russian and Eastern European CRO, and Global Medical Institutes, LLC a United States SMO with  specialization in neuroscience research.  Dr. Selivra is responsible for day-to-day operations, corporate financial oversight and strategic development of both companies.
He has over 18 years of clinical research experience having managed organizations in Arkansas, Florida and New York.  Prior to joining Global Medical Institutes, Dr. Selivra established and directed Winthrop-South Nassau University Health System Clinical Trials Network on Long Island.  Dr. Selivra is well recognized expert in patient recruitment for CNS research projects both in the United States and in Eastern Europe.